Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06784882 · ClinicalTrials.gov registry record · Phase 4
Continuous Versus Single Injection Adductor Canal Blocks for Outpatient Total Knee Arthroplasty
A Phase 4 study of Surgery and Acute Post Operative Pain, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06784882: Recruiting Phase 4 study of Surgery and Acute Post Operative Pain, sponsored by University of California, San Diego.
NCT06784882 is a Phase 4 study of Surgery and Acute Post Operative Pain that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 40 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06784882, a Phase 4 study of Surgery and Acute Post Operative Pain, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center pilot study to determine if an adductor canal continuous nerve block is superior to single injection nerve block following total knee arthroplasty. Investigators will randomize participants to either continuous nerve block or single injection nerve block for the adductor canal preoperatively. They will assess differences in pain (measured in numeric rating scale), opioid consumption, and physical therapy milestones from postoperative day 0 to 7.
Primary Outcome
Numeric Rating Scale (NRS) for pain will be superior daily with continuous adductor canal blocks on postoperative days 1-7 following total ankle arthroplasty as compared with single-injection adductor canal blocks (as measured by the "average" daily NRS within the Brief Pain Inventory)
Conditions Studied
Interventions
- DEVICE continuous peripheral nerve block with OnQ pump
- DRUG single injection nerve block
Study Locations (1)
California
- University of California, San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2025-12-01 |
| Phase | Phase 4 |
What NCT06784882 shows while recruiting
NCT06784882 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which continuous peripheral nerve block with OnQ pump is the first listed.
NCT06784882 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06784882 about?
NCT06784882 is a clinical study titled "Continuous Versus Single Injection Adductor Canal Blocks for Outpatient Total Knee Arthroplasty". This is a single-center pilot study to determine if an adductor canal continuous nerve block is superior to single injection nerve block following total knee arthroplasty. Investigators will randomize participants to either continuous nerve block or single injection nerve block for the adductor cana...
What is the current status of trial NCT06784882?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2025-06-01. Estimated completion is 2025-12-01.
What conditions does trial NCT06784882 study?
This clinical trial studies the following conditions: Surgery, Acute Post Operative Pain.
What interventions are being tested in trial NCT06784882?
The interventions under investigation include: continuous peripheral nerve block with OnQ pump (DEVICE), single injection nerve block (DRUG).
Who is sponsoring clinical trial NCT06784882?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06784882 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06784882's enrollment target sits among peer trials
40 100th of 120 higher than 19 of 120 other Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial
RECRUITING · Phase 4
-
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
RECRUITING · Phase 4
-
Multimodal Analgesia Effect on Post Surgical Patient
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI